A screening tool has high sensitivity and specificity for identifying use of illicit drugs and prescription medications, which might be useful to address an opioid epidemic and high rates of overdose deaths across the U.S.
6 Jun 2017
The U.S. Preventive Services Task Force recently concluded that for adults up to age 65 years, including those who are pregnant or postpartum, screening for anxiety is beneficial and should be conducted routinely in primary care.
1 Oct 2023
Rates of substance abuse treatment remain low for opioid use disorders despite their rapidly rising incidence
While the greatest increases occurred in inpatient treatment and at physicians' offices, medication-assisted treatments were often unavailable in inpatient settings.
20 Oct 2015
With nearly 63% of physicians reporting one or more signs of burnout, two experts offered advice on making changes to help prevent it.
1 Jul 2023
Persons with substance abuse problems who received chronic care management, including relapse prevention counseling and medical, addiction and psychiatric treatment, were no more abstinent than those who received usual primary care, a study found.
24 Sep 2013
The U.S. government no longer requires an X waiver to treat patients with buprenorphine for opioid use disorder.
1 Mar 2023
New research looks at COVID-19 quarantine length in asymptomatic contacts, convalescent plasma for mild disease, related health issues
Seven-day quarantine may be sufficient for contacts without symptoms, older adults with mild disease may benefit from convalescent plasma, and cardiovascular deaths increased during the early stage of the pandemic.
12 Jan 2021
A randomized clinical trial looked at the effects of a visual campaign and a narrative vignette on stigmas surrounding opioid use disorder.
1 Jun 2022
The guide provides information for clinicians on common terminology and initial evaluation, medical management, transgender-specific surgical options, medicolegal and societal issues, and practice improvement.
2 Jul 2019
While effective medications to treat opioid addiction are available in primary care, few physicians prescribe buprenorphine or naltrexone, and few would obtain the Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine.
1 Nov 2020